Evidence map›Paper›PMID 38400611›Full record

ArticleJournal of medical radiation sciences2024

Single high-energy arc proton therapy with Bragg peak boost (SHARP).

Scott N Penfold, Alexandre M C Santos, Melanie Penfold, Emma Shierlaw, Rosanna Crain

Abstract read
In one paragraph

Article in Journal of medical radiation sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Scott N PenfoldAustralian Bragg Centre for Proton Therapy and Research, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0002-3422-9108
Alexandre M C SantosAustralian Bragg Centre for Proton Therapy and Research, Adelaide, South Australia, Australia.
Melanie PenfoldAustralian Bragg Centre for Proton Therapy and Research, Adelaide, South Australia, Australia.ORCID https://orcid.org/0009-0005-5596-9737
Emma ShierlawAustralian Bragg Centre for Proton Therapy and Research, Adelaide, South Australia, Australia.
Rosanna CrainAustralian Bragg Centre for Proton Therapy and Research, Adelaide, South Australia, Australia.

Funding

Hospital Research Foundation 2021/45-QA25310
6 · The paper itself

Abstract

introductionBecause of the co-location of critical organs at risk, base of skull tumours require steep dose gradients to achieve the prescribed dosimetric criteria. When available, proton beam therapy (PBT) is often considered a desirable modality for these cases, but in many instances, compromises in target coverage are still required to achieve critical organ at risk (OAR) tolerance doses. A number of techniques have been proposed to further improve the penumbra of PBT. In the current study, we propose a novel, collimator-free treatment planning technique that combines high-energy shoot-through proton beams with conventional Bragg peak spot placement. The small spot size of the high-energy pencil beams provides a sharp penumbra at the target boundary, and the Bragg peak spots provide a higher linear energy transfer (LET) boost to the target centre.

methodsThree base of skull chordoma patients were retrospectively planned with three different PBT treatment planning techniques: (1) conventional intensity-modulated proton therapy (IMPT); (2) high-energy proton arc therapy (HE-PAT); and (3) the novel technique combining HE-PAT and IMPT, referred to as single high-energy arc with Bragg peak boost (SHARP). The Monaco 6 treatment planning system was used.

resultsSHARP was found to improve the PBT penumbra in the plane perpendicular to the HE-PAT beams. Minimal penumbra differences were observed in the plane of the HE-PAT beams. SHARP reduced dose-averaged LET to surrounding organs at risk.

conclusionA novel PBT treatment planning technique was successfully implemented. Initial results indicate the potential for SHARP to improve the penumbra of PBT treatments for base of skull tumours.

Indexed as

NeoplasmsProton TherapyRadiotherapy, Intensity-ModulatedHumansProtonsRadiotherapy DosageRadiotherapy Planning, Computer-AssistedRetrospective StudiesProtonsintensity‐modulated proton therapyproton arc therapyproton therapy treatment planning

Identifiers

PMID38400611
PMCPMC11011576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.